Analysis of the effect of fecal SDC2, ADHFE1 and PPP2R5C gene methylation test for screening colorectal cancer in the Otog Front Banner.

BMC Gastroenterol · 2025 · PMC12042555 · PMID 40307680

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Both FIT and Cologuard indicate that there may be significant costs associated with saving colorectal cancer screening methods, with FIT as the primary non-invasive method [ 31 ].

also in 7,550 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.